anmelden
Swiss All Share Index
18.742,62
PKT
-48,52
PKT
-0,26
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 09.11.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 09.11.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Swiss Re reduce | Nomura | |
| 09.11.12 | UBS outperform | Cheuvreux SA | |
| 09.11.12 | Swisscom neutral | Sarasin Research | |
| 09.11.12 | Swatch (I) buy | Sarasin Research | |
| 09.11.12 | Richemont neutral | Sarasin Research | |
| 09.11.12 | Swisscom hold | Vontobel Research | |
| 09.11.12 | Swiss Re buy | Vontobel Research | |
| 09.11.12 | Richemont buy | Vontobel Research | |
| 08.11.12 | UBS overweight | HSBC | |
| 08.11.12 | UBS neutral | HSBC | |
| 08.11.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 08.11.12 | Barry Callebaut neutral | UBS AG | |
| 08.11.12 | Barry Callebaut hold | Société Générale Group S.A. (SG) | |
| 08.11.12 | Swisscom hold | Vontobel Research | |
| 08.11.12 | Barry Callebaut hold | Vontobel Research | |
| 08.11.12 | Novartis reduce | Vontobel Research | |
| 08.11.12 | Swiss Re buy | Vontobel Research | |
| 08.11.12 | Swiss Re neutral | Sarasin Research | |
| 08.11.12 | Holcim hold | Vontobel Research | |
| 08.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 07.11.12 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 07.11.12 | Sonova equal-weight | Morgan Stanley | |
| 07.11.12 | Barry Callebaut hold | Vontobel Research | |
| 07.11.12 | Novartis reduce | Vontobel Research | |
| 07.11.12 | Adecco SA buy | Vontobel Research | |
| 07.11.12 | Holcim neutral | Sarasin Research | |
| 07.11.12 | Barry Callebaut neutral | Sarasin Research | |
| 07.11.12 | Schindler hold | Vontobel Research | |
| 07.11.12 | Holcim hold | Vontobel Research | |
| 07.11.12 | Adecco SA outperform | Exane-BNP Paribas SA | |
| 07.11.12 | Adecco SA neutral | J.P. Morgan Cazenove | |
| 07.11.12 | UBS buy | Vontobel Research | |
| 06.11.12 | Avolta (ex Dufry) outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Avolta (ex Dufry) neutral | UBS AG | |
| 06.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove |